Skip to content
  • 6,813 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started

Sources sought, total small business set-aside

Sources Sought Notice FDA Office of Clinical Pharmacology (OCP)/Division of Applied Regulatory Science (DARS) Purchase of Phenomenex High-Pressure Liquid Chromatography (HPLC) Core-Shell Technology Columns and Consumables

CDER-OTS-25-C-1691

Food and Drug Administration, FDA Office of Acq Grant SVCS. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

Response deadline

July 1, 2025 at 5:00 AM EDT

Closed 488 days ago. Posted June 24, 2025. Scheduled to archive July 16, 2025.

Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities

This one closed in 2025

127 like it are open now in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)

All 127 open in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)

Description

As published on SAM.gov.

The Food and Drug Administration (FDA) is seeking to purchase critical supplies neccesary for the Division of Applied Regulatory Science (DARS) bioanalytical lab to continue supporting mission- critical research focused on review questions, translational science, and emerging public health issues for the Center for Drug Evaluation and Research (CDER) and FDA.

DARS operates six total labs that focus on developing and evaluating novel tools, standards, and approaches that increase the regulatory efficiency of developing and reviewing safe and effective CDER products. These operational supplies are essential for the continuance of these projects across all lab groups, and for continued preparedness to be able to respond to emergent public health issues when called upon. We kindly request that each interested vendor also complete and submit the attached vendor feedback form along with a capability statement for consideration.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. June 24, 2025

    Sources sought

    Due July 1, 2025 at 5:00 AM EDT. SAM.gov, notice 5e9d911b92e047ec859af4b5aa3d66f0

Points of contact